Jose Carmona's most recent trade in Adc Therapeutics SA was a trade of 271,600 Common Shares done at an average price of $4.0 . Disclosure was reported to the exchange on Feb. 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adc Therapeutics SA | Jose Carmona | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.99 per share. | 13 Feb 2026 | 271,600 | 760,256 | - | 4.0 | 1,083,684 | Common Shares |
| Adc Therapeutics SA | Jose Carmona | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.99 per share. | 13 Feb 2026 | 25,880 | 734,376 | - | 4.0 | 103,261 | Common Shares |
| Adc Therapeutics SA | Jose Carmona | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.29 per share. | 06 Dec 2025 | 53,236 | 488,656 | - | 3.3 | 175,146 | Common Shares |
| Adc Therapeutics SA | Jose Carmona | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 240,000 | 541,892 | - | 1.6 | 386,400 | Common Shares |
| Adc Therapeutics SA | Jose Carmona | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 48,108 | 301,892 | - | 3.1 | 150,578 | Common Shares |